netFormulary NHS
Sandwell & West Birmingham
Clinical Commissioning Group
 Introduction

Welcome to Sandwell & West Birmingham CCG Formulary

Useful Links

 Covid-19 Resources    
Delivering Diabetes Care during the COVID-19 Pandemic – the ‘new normal’ - Guidance for General Practice  COVID-19 and diabetes - At a glance factsheet NHS Diabetes Advice Helpline - FAQs
     
 COVID-19 SITUATION v1.3 Lower Limb Amputation Prevention Guidance Sick day rules: how to manage Type 2 diabetes if you become unwell with coronavirus and what to do with your medication  Sick day rules for patients on multiple daily injections (MDI) OR PUMP THERAPY: how to manage Type 1 diabetes if you become unwell with coronavirus
     
Advice and guidance regarding Vitamin B12 IM Injections during the COVID-19 pandemic  Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19   Drug monitoring: factors to consider during Covid-19
     
Advice and guidance regarding DMARDs during COVID-19  NICE COVID-19 rapid guidance  IMPORTANT ADVICE TO KEEP YOU SAFE FROM CORONAVIRUS (COVID-19) - Letter for Patients 
     
Statement from JCVI on immunisation prioritisation  SWB CCG Emis Web eRD Guide SWB CCG SystmOne eRD Guide 
     
COVID-19: information for the respiratory community  Respiratory Inhalers supply chain problems   MHRA guidance on coronavirus (COVID-19)
     
FSRH CEU clinical advice to support provision of effective contraception during the COVID-19 outbreak  FSRH, RCOG & RCM statement provision of postpartum contraception during Covid-19  Example - contraception contingency plan during COVID-19 (Mar 2020) 
     
Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (COVID-19) pandemic  Administration of depot antipsychotic injections during COVID-19 in stable adult patients Clinical guide for the management of anticoagulant services during the coronavirus pandemic 
     
West Midlands, Palliative Care Physicans - Guidelines for the use of drugs in symptom control   Covid-19 & Specialist Palliative Care

 

 PCCF Standard 9, 2019/2020 Statement: click here

 

 

 Useful Links

SWBCCG
Homepage

UKMI

BNF

NICE Guidelines

Drug Tariff

Scottish Guidelines Network

Clinical Knowledge Summaries

NHS Choices

EMC

 Medication Review Guidance

A Good Practice Guide To Repeat Prescribing

A Good Practice Guide To Patient Returned Medication 

Items which should NOT be routinely prescribed in Primary Care Policy Conditions for which over the counter (OTC) medicines should NOT be routinely prescribed in Primary Care Policy DECISION TO DECLINE PRESCRIBING OF MEDICINES RECOMMENDED BY HOSPITAL SPECIALISTS 
Yellow Card Scheme  Central Alerting System (CAS) Homepage  Pharmacy Minor Ailment Scheme (PMAS) - Quick reference guide 

 

 

 

 

News Feed

 Dexamethasone and COVID-19

The Black Country and West Birmingham CCG have jointly delivered a statement on the use of Dexamathasone in the treatment of COVID-19.

 

GOV.UK resources available on:  https://www.gov.uk/coronavirus

 

NICE Rapid Guidelines

NICE is supporting the NHS and social care by developing a series of rapid guidelines on caring for patients with suspected and confirmed COVID-19 infection, and patients without COVID-19 infection, in a number of clinical areas.

These include

  1. Severe asthma
  2. Managing suspected or confirmed pneumonia in adults in the community
  3. Rheumatological autoimmune, inflammatory and metabolic bone disorders
  4. Managing symptoms (including at the end of life) in the community
  5. Cystic Fibrosis
  6. Community-based care of patients with Chronic Obstructive Pulmonary Disease (COPD)
  7. Dermatological conditions treated with drugs affecting the immune response
  8. Gastrointestinal and liver conditions treated with drugs affecting the immune response
  9. Acute myocardial injury
  10. Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19
  11. Chronic Kidney Disease
  12. Interstitial Lung Disease

 


NICE have now published the COVID-19 rapid guideline: Managing suspected or confirmed pneumonia in adults in the community

Please refer to NICE guidance (above) for full details. Extract from this document:

  • As COVID19 pneumonia is caused by a virus, antibiotics are not effective.
  • Do not offer an antibiotic for the treatment or prevention of pneumonia if COVID 19 is the likely cause, and symptoms are mild.
    • Inappropriate antibiotic use may reduce availability if used indiscriminately
    • Broad spectrum antibiotics may lead to a C-Diff infection as well as increasing antibiotic resistance
  • Offer an oral antibiotic for treatment of pneumonia in people who can or wish to be treated in the community if:
    • The likely cause is bacterial or
    • The cause is unclear and symptoms are more concerning or
    • They are at high risk of complications. For example, they are older or frail, or have a pre-existing comorbidity such as immunosuppression or significant heart or lung disease (e.g. bronchiectasis or COPD), or have a history of severe illness following previous lung infection.

Additional notes:

  • Inappropriate use of antibiotics can cause more harm than good
  • Follow current NICE guidance and do not change evidence based prescribing behaviours and advise self-care where clinically appropriate
  • Only prescribe rescue packs, including antibiotics, if they are part of the patients existing asthma/COPD plan
  • NHS England are due to advise no prepack antibiotic use in care homes
  • The antibiotic supply line is already stressed with out of stocks. Prudent use is advised
  • Refer to guidelines and prescribe no more than the usual quantity as over-prescribing will put more pressure on the national supply chain.

 


Management of a suspected case of COVID-19 Flowchart

 


BSSE APC Primary Care Clinical Pathway for Atrial Fibrillation Detection and Management (Nov 2019)

 


Welcome to the Sandwell and West Birmingham CCG Health Economy Formulary. This formulary has been overseen by Sandwell and West Birmingham DTC which consists of a number of GPs, consultants and pharmacists from the health economy. Choices are based on clinical evidence, safety and cost-effectiveness. The formulary aims to provide information on the medicines recommended for prescribing within Sandwell and West Birmingham CCG.

 

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing. 

 

Ethical and religious implications of animal derived substances in medicines

Drugs with animal and human derived content are widely used in medicine and surgery across the world. However, information regarding the origins of specific ingredients is not always available to health practitioners. A religious/ethical perspective concerning the use of animal and human derived drug ingredients has not thoroughly been investigated. This article https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220589/ from December 2013 demonstrates the breadth and complexity of this issue.


The APC accepts that individuals may wish to avoid using medication that is in any way derived from animal and human origin (or containing alcohol) in order to support their ethical or religious views. When this view is expressed to prescribers, they will seek to find a formulary product with a suitable formulation. However, it is important to note that often, suitable alternatives may not be available. Following discussion with their doctor/prescriber - the individual should then make an informed decision regarding their choice to take the prescribed medication or not.
Medicine formulations are subject to change, therefore the APC does not identify specific products as being suitable for individuals with any specific religious or ethical view.

Individuals may seek the advice of their local community pharmacist regarding the suitability of medicines.


NetFormulary
   Last updated: 18/09/2020 13:36:45..
    Download net formulary from Apple IOS Store  Google Play net formulary